RPL39 Was Associated With Sex Differences in Pulmonary Arterial Hypertension

Overview

Journal Can Respir J

Publisher Wiley

Specialty Pulmonary Medicine

Date 2025 Feb 17

PMID 39957991

Authors

Haixia Wang

Ling Li

Guangyuan Zhou

Lu Wang

Zeang Wu

Affiliations

Soon will be listed here.

Abstract

Pulmonary arterial hypertension (PAH) is a malignant cardiovascular disease with a complex etiology, in which several types of cells play important roles. Sex differences in disease susceptibility and survival have been observed in PAH patients, but few studies have analyzed the effect of changes in cell type and number on sex differences in PAH at the single-cell level. In this study, we performed a series of analyses on GSE169471 and GSE228644 datasets and found significant changes in the ratio of several types of cells in male PAH lung tissues. Surprisingly, we found that the ratio of macrophages in male PAH samples was 7 times higher than that in females. Consistently, the ratio of M1 macrophages was also significantly increased in male PAH samples. The different expression genes (DEGs) in macrophages were mainly involved in the ribosome pathway, which is closely related to cell proliferation. Inhibition of ribosomal protein L39 (RPL39), a core gene in the ribosome pathway, can inhibit macrophage proliferation and attenuate the sex differences in PAH. In conclusion, our study suggests that ribosome pathway-associated cell proliferation of macrophages might be associated with sex differences in PAH.

References

Sherman B, Hao M, Qiu J, Jiao X, Baseler M, Lane H . DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022; 50(W1):W216-W221. PMC: 9252805. DOI: 10.1093/nar/gkac194. View

Hong J, Arneson D, Umar S, Ruffenach G, Cunningham C, Ahn I . Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning. Am J Respir Crit Care Med. 2020; 203(8):1006-1022. PMC: 8048757. DOI: 10.1164/rccm.202006-2169OC. View

Rabinovitch M, Guignabert C, Humbert M, Nicolls M . Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014; 115(1):165-75. PMC: 4097142. DOI: 10.1161/CIRCRESAHA.113.301141. View

Wang W, Nag S, Zhang X, Wang M, Wang H, Zhou J . Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev. 2014; 35(2):225-85. PMC: 4710177. DOI: 10.1002/med.21327. View

Prakash V, Carson B, Feenstra J, Dass R, Sekyrova P, Hoshino A . Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease. Nat Commun. 2019; 10(1):2110. PMC: 6506521. DOI: 10.1038/s41467-019-10100-8. View

Liu J, Wang W, Wang L, Chen S, Tian B, Huang K . IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells. EBioMedicine. 2018; 33:196-210. PMC: 6085568. DOI: 10.1016/j.ebiom.2018.06.003. View

Saygin D, Tabib T, Bittar H, Valenzi E, Sembrat J, Chan S . Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension. Pulm Circ. 2020; 10(1). PMC: 7052475. DOI: 10.1177/2045894020908782. View

Jie Q, Sun F, Li Q, Zhu J, Wei Y, Yang H . Downregulated ribosomal protein L39 inhibits trophoblast cell migration and invasion by targeting E-cadherin in the placenta of patients with preeclampsia. FASEB J. 2021; 35(4):e21322. DOI: 10.1096/fj.202002061R. View

Batton K, Austin C, Bruno K, Burger C, Shapiro B, Fairweather D . Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. Biol Sex Differ. 2018; 9(1):15. PMC: 5907450. DOI: 10.1186/s13293-018-0176-8. View

10.

Mair K, Johansen A, Wright A, Wallace E, MacLean M . Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol. 2013; 171(3):567-79. PMC: 3969073. DOI: 10.1111/bph.12281. View

11.

Aran D, Looney A, Liu L, Wu E, Fong V, Hsu A . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019; 20(2):163-172. PMC: 6340744. DOI: 10.1038/s41590-018-0276-y. View

12.

Dave B, Granados-Principal S, Zhu R, Benz S, Rabizadeh S, Soon-Shiong P . Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling. Proc Natl Acad Sci U S A. 2014; 111(24):8838-43. PMC: 4066479. DOI: 10.1073/pnas.1320769111. View

13.

Thenappan T, Goel A, Marsboom G, Fang Y, Toth P, Zhang H . A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med. 2010; 183(8):1080-91. PMC: 3086745. DOI: 10.1164/rccm.201008-1303OC. View

14.

Yaku A, Inagaki T, Asano R, Okazawa M, Mori H, Sato A . Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages. Circulation. 2022; 146(13):1006-1022. DOI: 10.1161/CIRCULATIONAHA.122.059435. View

15.

Zhang J, Lu X, Liu M, Fan H, Zheng H, Zhang S . Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension. Cardiovasc Res. 2019; 116(13):2156-2169. DOI: 10.1093/cvr/cvz312. View

16.

Lu X, Zhang J, Liu H, Ma W, Yu L, Tan X . Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function. Theranostics. 2021; 11(11):5267-5278. PMC: 8039951. DOI: 10.7150/thno.55571. View

17.

Hester J, Ventetuolo C, Lahm T . Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure. Compr Physiol. 2019; 10(1):125-170. PMC: 7338988. DOI: 10.1002/cphy.c190011. View

18.

Umar S, Rabinovitch M, Eghbali M . Estrogen paradox in pulmonary hypertension: current controversies and future perspectives. Am J Respir Crit Care Med. 2012; 186(2):125-31. PMC: 3406082. DOI: 10.1164/rccm.201201-0058PP. View

19.

Umar S, Cunningham C, Itoh Y, Moazeni S, Vaillancourt M, Sarji S . The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension. Am J Respir Crit Care Med. 2017; 197(7):952-955. PMC: 6020406. DOI: 10.1164/rccm.201707-1345LE. View

20.

Li C, Chen D, Luo M, Ge M, Zhu J . Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo. Biotechnol J. 2014; 9(5):652-63. DOI: 10.1002/biot.201300321. View